LLY

1,014.98

-0.96%↓

JNJ

240.9

+1.12%↑

ABBV

220.69

-0.72%↓

NVS

159.71

+1.01%↑

MRK

119.32

+1.9%↑

LLY

1,014.98

-0.96%↓

JNJ

240.9

+1.12%↑

ABBV

220.69

-0.72%↓

NVS

159.71

+1.01%↑

MRK

119.32

+1.9%↑

LLY

1,014.98

-0.96%↓

JNJ

240.9

+1.12%↑

ABBV

220.69

-0.72%↓

NVS

159.71

+1.01%↑

MRK

119.32

+1.9%↑

LLY

1,014.98

-0.96%↓

JNJ

240.9

+1.12%↑

ABBV

220.69

-0.72%↓

NVS

159.71

+1.01%↑

MRK

119.32

+1.9%↑

LLY

1,014.98

-0.96%↓

JNJ

240.9

+1.12%↑

ABBV

220.69

-0.72%↓

NVS

159.71

+1.01%↑

MRK

119.32

+1.9%↑

Search

Orthofix International NV

Открыт

СекторЗдравоохранение

13.14 0.84

Обзор

Изменение цены акций

24 ч

Текущая

Мин.

12.95

Макс.

13.5

Ключевые показатели

By Trading Economics

Доход

-8.7M

-23M

Продажи

2.5M

206M

Прибыль на акцию

0.198

Рентабельность продаж

-11.085

Сотрудники

1,616

EBITDA

-11M

-3.1M

Рекомендации

By TipRanks

Рекомендации

Покупка

Прогноз на 12 месяцев

+45.48% upside

Дивиденды

By Dow Jones

Следующий отчет о доходах

24 февр. 2026 г.

Рыночная статистика

By TradingEconomics

Рыночная капитализация

-117M

517M

Предыдущая цена открытия

12.3

Предыдущая цена закрытия

13.14

Новостные настроения

By Acuity

50%

50%

149 / 352 Рейтинг в Healthcare

Техническая оценка

By Trading Central

Уверенность

Weak Bearish Evidence

Orthofix International NV График

Прошлые результаты не являются надежным индикатором будущих результатов.

Связанные новости

11 февр. 2026 г., 23:47 UTC

Популярные акции

Stocks to Watch: AppLovin, Cisco, Cognex, Pilgrim's Pride

11 февр. 2026 г., 22:59 UTC

Отчет
Приобретения, слияния, поглощения

Grab Holdings to Buy U.S.-Based Stash Financial

11 февр. 2026 г., 23:54 UTC

Отчет

McDonald's Says Its Value Campaign Is Paying Off -- 2nd Update

11 февр. 2026 г., 23:50 UTC

Обсуждения рынка

Global Equities Roundup: Market Talk

11 февр. 2026 г., 23:50 UTC

Обсуждения рынка

Nikkei May Rise on Hopes for Takaichi's Economic Steps -- Market Talk

11 февр. 2026 г., 23:49 UTC

Отчет

Singtel: Key Focus Areas Are Strengthening Core Businesses, Scaling Growth Engines, Building Momentum Across Regional Associates >Z74.SG

11 февр. 2026 г., 23:45 UTC

Отчет

Singtel: Net Exceptional Gain of S$1.15B in 3Q Primarily From Sale of Partial Stake in Bharti Airtel>Z74.SG

11 февр. 2026 г., 23:42 UTC

Отчет

Singtel 3Q Underlying Net Profit S$744M Vs. S$680M >Z74.SG

11 февр. 2026 г., 23:41 UTC

Отчет

Singtel 3Q Net S$1.89B Vs. Net S$1.32B >Z74.SG

11 февр. 2026 г., 23:40 UTC

Отчет

Singtel 3Q Operating Revenue S$3.66B Vs. S$3.63B >Z74.SG

11 февр. 2026 г., 23:35 UTC

Обсуждения рынка

Gold Falls on Prospects of Long Fed Pause -- Market Talk

11 февр. 2026 г., 23:18 UTC

Обсуждения рынка

AppLovin CEO Looks to Soothe Concerns Over AI, Competition -- Market Talk

11 февр. 2026 г., 23:14 UTC

Обсуждения рынка

RBA Governor Faces Barrage of Questions About Govt Spending -- Market Talk

11 февр. 2026 г., 22:59 UTC

Отчет

Kakao 2025 Net KRW525.72B Vs. Loss KRW161.87B >035720.SE

11 февр. 2026 г., 22:59 UTC

Отчет

Kakao 2025 Oper Pft KRW732.04B Vs. Pft KRW460.21B >035720.SE

11 февр. 2026 г., 22:59 UTC

Отчет

Kakao 2025 Rev KRW8.099T Vs. KRW7.872T >035720.SE

11 февр. 2026 г., 22:58 UTC

Отчет

Kakao 4Q Net Loss Missed FactSet-Compiled Consensus

11 февр. 2026 г., 22:57 UTC

Отчет

Kakao 4Q Loss KRW39.30B Vs. Loss KRW395.21B >035720.SE

11 февр. 2026 г., 22:54 UTC

Отчет

Kakao 4Q Oper Pft KRW203.45B Vs. Pft KRW75.43B >035720.SE

11 февр. 2026 г., 22:53 UTC

Отчет

Kakao 4Q Rev KRW2.133T Vs. KRW1.957T >035720.SE

11 февр. 2026 г., 22:47 UTC

Отчет

AppLovin Reports Strong Earnings. The Stock Is Down. -- Barrons.com

11 февр. 2026 г., 22:47 UTC

Отчет

AppLovin Reports Strong Earnings. The Stock Is Down. -- Barrons.com

11 февр. 2026 г., 22:23 UTC

Отчет

Grab Holdings Expects to Close Stash Acquisition in 3Q of 2026 >GRAB

11 февр. 2026 г., 22:22 UTC

Отчет

Grab Holdings to Acquire U.S. Digital Financial Services Company Stash Financial >GRAB

11 февр. 2026 г., 22:22 UTC

Отчет

Grab Holdings Sees FY26 Adj Ebitda $700M to $720M >GRAB

11 февр. 2026 г., 22:19 UTC

Отчет

Grab Holdings Sees FY26 Rev $4.04B to $4.10B >GRAB

11 февр. 2026 г., 22:18 UTC

Отчет

Grab Holdings 4Q Adj Ebitda $148.0M Vs. $97.0M >GRAB

11 февр. 2026 г., 22:18 UTC

Отчет

Grab Holdings 4Q Net $153.0M Vs. Net $11.0M >GRAB

11 февр. 2026 г., 22:18 UTC

Отчет

Grab Holdings 4Q Oper Pft $52.0M Vs. $2.0M >GRAB

11 февр. 2026 г., 22:16 UTC

Отчет

Grab Holdings 4Q Rev $906.0M Vs. $764.0M >GRAB

Сравнение c конкурентами

Изменение цены

Orthofix International NV Прогноз

Целевая цена

By TipRanks

45.48% рост

Прогноз на 12 месяцев

Средняя 19 USD  45.48%

Максимум 24 USD

Минимум 14 USD

Основано на мнении 2 аналитиков Wall Street, спрогнозировавших целевые цены для Orthofix International NV на следующие 12 месяцев – Данные за последние 3 месяца.

Консенсус по рейтингу

By TipRanks

Покупка

2 ratings

1

Покупка

1

Удержание

0

Продажа

Техническая оценка

By Trading Central

10.4 / 12.1Поддержка и Сопротивление

Краткосрочная

Weak Bearish Evidence

Среднесрочная

Bearish Evidence

Долгосрочная

Bearish Evidence

Настроения

By Acuity

149 / 352Рейтинг в Здравоохранение

Новостные настроения

Neutral

Волатильность

Ниже среднего

Объем новостей (RCV)

Ниже среднего

Финансовые показатели

Расходы на продажи и администрирование

Операционные расходы

Прибыль до уплаты налогов

Продажи

Себестоимость реализации

Валовая прибыль от продаж

Процентные расходы по долгу

EBITDA

Операционная прибыль

$

О компании Orthofix International NV

Orthofix Medical Inc. operates as a spine and orthopedics company in the United States, Italy, Germany, the United Kingdom, France, Brazil, and internationally. It operates through two segments, Global Spine and Global Orthopedics. The Global Spine segment manufactures and distributes bone growth stimulator devices for enhance of bone fusion, including adjunctive and noninvasive treatment of cervical and lumbar spine, as well as a therapeutic treatment for non-spine; designs, develops, and markets a portfolio of motion preservation and fixation implant products, which are used in surgical procedures of the spine; and offers biological products, such as fiber-based and particulate demineralized bone matrices, cellular bone allografts, collagen ceramic matrices, and synthetic bone void fillers, and tissue forms, which allow physicians to treat various spinal and orthopedic conditions. This segment also designs, develops, and markets a portfolio of navigation technologies, including tracked surgical tools, intelligent software, and imaging equipment based on machine-vision and optical innovations. The Global Orthopedics segment offers products and solutions that allow physicians to treat various orthopedic conditions related to limb reconstruction and deformity correction unrelated to the spine. This segment designs, develops, and markets external and internal fixation orthopedic products that are coupled with enabling digital technologies to serve the complete patient treatment pathway. It sells its products through distributors and sales representatives to hospitals, healthcare organizations, and healthcare providers. The company was formerly known as Orthofix International N.V. and changed its name to Orthofix Medical Inc. in 2018. Orthofix Medical Inc. was founded in 1980 and is headquartered in Lewisville, Texas.
help-icon Live chat